Applications published 20 December 2006
Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose
Novartis 1732511*
Inhalant formulation containing sulphoalkyl ether cyclodextrin and corticosteroid
Cydex 1732512*
Rosiglitazone formulations
Alpharma 1732513*
Crystalline compsn containing escital oxalate
H Lundbeck 1732514*
Dry powder preparations for pre-metered SPI
Mederio 1732515*
Ion binding compsns
Ilypsa 1732516*
Prolonged-release compsns comprising torasemide and a matrix-forming polymer
Ferrer Internacional 1732517*
Clarithromycin extended release formulation
Lupin 1732518*
Oral matrix formulations comprising licarbazepine
Novartis 1732519*
Drug delivery system based on polyethylene vinylacetate copolymers
NV Organon 1732520*
Compression-coated tablets and manufacture thereof
Arrow No 7 1732521*
Gastric retention system
Sun Pharmaceutical Industries 1732522*
Non binding polymers and uses thereof
Ilypsa 1732523*
Methods and compsns for treatment of ion imbalances
Ilypsa 1732524*
Amorolfine patch for treating onychomycosis
Galderma Research & Development 1732525*
Salmeterol inhalation formulations
Cipla 1732526*
Use and administration of bacterial efflux pump inhibitors
MPEX Pharmaceuticals 1732527*
Bazedoxifene acetate solid dispersion formulations
Wyeth 1732528*
Gossypol co-crystals and the use thereof
The Regents of the University of Michigan 1732529*
1-aminocyclohexane derivatives for the treatment of agitation and other behavioural disorders, especially those associated with Alzheimer's disease
Merz Pharma 1732530*
Amines and amides for the treatment of diseases
La Jolla Pharmaceutical 1732531*
Novel pharmaceutical compsns comprising agonists of the thyroid receptor
Karo Bio 1732532*
Thyroid receptor agonists
Karo Bio 1732533*
Use of methylene amide derivatives in cardiovascular disorders
Applied Research Systems 1732534*
Injectable compsns for the treatment of cancers
Jee, Ung-Kil 1732535*
Triptolide lactone ring derivatives as immunomodulators and anticancer agents
Pharmagenesis 1732536*
Benzofuran derivatives for the treatment of cardiac arrhythmia
Aryx Therapeutics 1732537*
Use of a serine palmitoyltransferase (SPT) inhibitor to treat atherosclerosis and dyslipidaemia
Warner-Lambert 1732538*
Use of beta-lapachone for the treatment of colon cancer
Arqule 1732539*
Oral health care drink and method for reducing malodours
Tasker Products IP Holdings 1732540*
Cyclic compounds
Takeda Pharmaceuticals 1732541*
Use of a metronidazole for preparing a pharmaceutical compsn for treating a cutaneous vascularisation disorder
Galderma Research & Development 1732542*
Tetra-cyclic carboline derivatives for inhibiting angiogenesis
PTC Therapeutics 1732543*
Treatment of tremor with histamine H3 inverse agonists or histamine H3 antagonists
Merck 1732544*
Tetrahydro-beta-carboline compounds and use thereof
MediQuest Therapeutics 1732545*
Novel pyrrolo (2,3-B)pyridine derivatives, the preparation and the pharmaceutical use thereof in the form of kinase inhibitors
Aventis Pharma 1732546*
Anti-HIV quinuclidine compounds
Samaritan Pharmaceuticals 1732547*
Methods of using sustained release aminopyridine compsns
Acorda Therapeutics 1732548*
Methods for the treatment of synucleinopathies
The Brigham and Women's Hospital 1732549*
DPP-IV inhibitors for treating neurodegeneration and cognitive disorders
Novartis 1732550*
Perhexilin for treating chronic heart failure
Heart Metabolics 1732551*
2,6-disubstituted piperidines as modulators of chemokine receptor activity
Merck 1732552*
Compounds for treating proliferative processes
Boehringer Ingelheim International 1732553*
Treatment regimens for camptothecin derivatives
Novartis 1732554*
Opioid delivery system
Delex Therapeutics 1732555*
Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzo-pyran-2-one and salts and hydrates thereof
Solvay Pharmaceuticals 1732556*
1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
Solvay Pharmaceuticals 1732557*
1-[2H-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
Solvay Pharmaceuticals 1732558*
Methods of treatment using eszopiclone
Sepracor 1732559*
Substituted cinnolin-4-ylamines
Neurogen 1732560*
Combination of CB2 modulators and PDE4 inhibitors for use in medicine
Glaxo Group 1732561*
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
Arena Pharmaceuticals 1732562*
Methods for modulating glutamate receptors for treating neuropsychiatric disorders comprising the use of modulators of serum and glucocorticoid inducible kinases
Merck Patent 1732563*
Biaryl substituted pyrazinones as sodium channel blockers
Merck 1732564*
Sustained-release oral molsidomine compsn for treating atherosclerosis
Therabel Pharmaceuticals 1732565*
6-azaindole compound
Takeda Pharmaceutical 1732566*
Use of a phenothiazine derivative for preventing and/or treating hearing loss
Societe de Conseils de Recherches et d'Applications Scientifiques 1732567*
Uses of erbeta modulators
University Court of the University of Edinburgh 1732568*
Use of adefovir or tenofovir for inhibiting MMTV-like viruses involved in breast cancer and primary biliary cirrhosis
Gilead Sciences 1732569*
Novel HIV protease inhibitors
Vysoka skola chemicko-technologicka v Praze; Ustrav organicke chemie a biochemie av cz; Department of virology, University of Heidelberg 1732570*
Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics
Archemix 1732571*
Control of feeding behaviour by changing neuronal energy balance
Fasgen; The Johns Hopkins University 1732572*
Biologically active compounds with anti-angiogenic properties
Alchemia 1732573*
The uses of O-ATP for the treatment of diseases involving angiogenesis
Universitàdegli studi di Milano 1732574*
Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
Osteologix 1732575*
Method for the photostabilisation of phycobiliproteins in an aqueous extract, compsns containing stabilised phycobiliproteins and use of stabilised phycobiliproteins
Minard, Florence 1732576*
Topical delivery of a nitric oxide donor to improve body and skin appearance
Strategic Science & Technologies 1732577*
Plant -based medicament for the treatment of hepatitis C
Phynova 1732578*
Herbal extract for renal disorders
Nicholas Piramal India 1732579*
EPHA2 vaccines
Medimmune 1732580*
Polypeptide transduction and fusogenic peptides
The Regents of the University of California San Diego 1732581*
Diagnosis of hyperinsulinemia and type II diabetes and protection against same based on genes differentially expressed in muscle cells
Ohio University 1732582*
Combinatorial therapies for the treatment of neoplasis using the opioid growth factor receptor
The Penn State Research Foundation 1732583*
Multicomponent biological transport systems
ReVance Therapeutics 1732584*
Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
Institut Gustave Roussy; Centre National de la Recherche Scientifique; Universite de Paris-Sud 1732585*
Uses of melancortin-4 receptor (MC4R) agonist peptides administered by continuous infusion
Eli Lilly 1732586*
Methods of protein fractionation using high performance tangential flow filtration
GTC Therapeutics 1732587*
Modulation of NKG2D
The Regents of the University of California 1732588*
BMP-3-propeptide and related methods
Acceleron Pharma 1732589*
New pharmaceutical compsn based on fluorenecarboxyclic acid esters and soluble TNF receptor fusion proteins
Boehringer Ingelheim Pharma 1732590*
Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
Ohno, Tsuneya 1732591*
Use of neuropeptides for ligament healing
Wisconsin Alumni Research Foundation 1732592*
Use of EPI-HNE 1-4
Coloplast 1732593*
Method for the delivery of sustained release agents
St Luke's Hospital 1732594*